Great Lakes NeuroTechnologies Eyes Deep Brain Stimulation Market for Parkinson's Disease

A neurotechnology company is planning a clinical study aimed at helping it enter the deep brain stimulation market for Parkinson’s disease patients. Cleveland-based Great Lakes NeuroTechnologies is aiming to help surgeons and neurologists fine-tune deep brain stimulation (DBS) systems after they’ve been implanted in Parkinson’s patients. DBS involves implanting an electrode in the brain to deliver electrical stimulation to block abnormal nerve signals that cause tremors, slowed movements and stiff joints that grow worse as Parkinson’s progresses in patients.